Bovactant (Aerogen Pharma/Lyomark)

N/A

Report date: 2025/03/03 14:38:10

Base Information

Drug NameBovactant (Aerogen Pharma/Lyomark)
Drug Alias Name牛肺表面活性剂勃法克坦AerofactAlveofactSF-R11 +[6
ClassificationNatural product/Extract > Animal extractBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, Newborn
Global Approved IndicationsRespiratory Distress Syndrome, Newborn
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1990/01/01
Country/TerritoryCanadaUnited StatesGermany +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
China Registration ClassN/A

Develop Information

Active IndicationsRespiratory Distress Syndrome, Newborn
Inactive IndicationsN/A

Other Information

ATC CodeR07AA
Related LinksN/A